Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Bone Marrow Stem Cells for Autism
NCT01740869Phase 3Completed
- Sponsor
- Hospital Universitario Dr. Jose E. Gonzalez
- Start
- Nov 2012
- Primary completion
- Nov 2016
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 3 trial of autologous CD34+ hematopoietic stem cells in Autism Spectrum Disorder (ASD), sponsored by Hospital Universitario Dr. Jose E. Gonzalez. Started Nov 2012; status: completed.
02
Drugs
autologous CD34+ hematopoietic stem cells
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT01740869.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01740869.